Picture

Verastem Oncology @VerastemOncolog

Verastem Oncology is committed to developing and commercializing medicines to improve the lives of patients with #RAS pathway-driven #cancers. $VSTM verastem.com Needham, MA Joined January 2018
  • Tweets
    1K
  • Followers
    3K
  • Following
    1K
  • Likes
    2K
VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

18 hours ago

We will be participating in a fireside chat at the RBC Capital Markets Global Healthcare Conference on May 14, 2024. The live audio webcast will be available on our website. $VSTM

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

6 days ago

Thank you to the @NOCC_National for sharing with our employees the incredible work you do every day to support people living with #ovariancancer and their loved ones/caregivers. #knowovarian

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 weeks ago

We are at the @oncologynursing's 2024 Annual Congress meeting. Stop by booth #3072 in the Learning Hall to learn more about our clinical trials for low-grade serous ovarian cancer (#LGSOC), pancreatic cancer, and NSCLC. #ONSCongress

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

4 weeks ago

The KRAS G12D mutation is the most prevalent #KRAS mutation across human cancers w/ no FDA-approved treatments. For the first time with partner GenFleet we will share preclinical data of GFH375/VS-7375, a potent & selective oral KRAS G12D (ON/OFF) inhibitor at #AACR24

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

a month ago

Tomorrow is #NationalDoctorsDay, we’re sharing @LUNGevity's #NoOneMissed HCP site, created to aid doctors in guiding non-small cell #lungcancer patients towards comprehensive #biomarkertesting & finding an optimal treatment plan: no1missed.org/3T8otox. Thank you #doctors! #LCSM

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

a month ago

Meet Shanta Peinado, a Medical Science Liaison who spends her time fostering relationships with opinion leaders and aiding our clinical trials through education and outreach. #VerastemOnc

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

While the @SGO_org Annual Meeting may be over, findings presented from our #LGSOCPatientImpactSurvey remain timely. Addressing #LGSOC doesn't end with treatment but includes holistic support to ease the burden placed on patients bit.ly/3IIgM2m #SGOmtg #cancer

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

Thank you, Nick Paul Taylor @FiercePharma for shedding light on the importance of raising awareness for rare cancers like #LGSOC, as evidenced by recent #LGSOCPatientImpactSurvey findings with medical leaders like Dr. Charlotte Sun and Dr. David Gershenson bit.ly/3PpTjH0

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

87% of surveyed patients w/ #LGSOC fear making long-term plans. Results from #LGSOCPatientImpactSurvey at #SGOmtg highlight the impact of LGSOC on patients' lives and the need for comprehensive support and treatment. bit.ly/3IIgM2m #PowerofSharedPurpose

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

Attending @SGO_org's Annual Meeting on Women's Cancer? Stop by our Booth 420 to learn more about our pipeline and advancements in #lowgradeserous #ovariancancer or #LGSOC. #SGOMtg #PowerofSharedPurpose

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

Today, we announced our Q4/FY23 financial results and highlighted our progress, including initiating a confirmatory Phase 3 trial evaluating avutometinib and defactinib in low-grade serous ovarian cancer.  $VSTM #LGSOC #Cancerresearch​ Learn more: bit.ly/43jKswn

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

With multiple oral presentations at this year's @SGO_org's Annual Meeting on Women's Cancer, we continue to highlight insights into #LGSOC from treatment and patient well-being perspectives.​ Learn more: bit.ly/3IuRdlx #SGOMtg #PowerofSharedPurpose

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

Today on #InternationalWomensDay and every day, we honor the resilience and strength of women worldwide. We are committed to illuminating pathways of hope and healing, particularly in RAS pathway-driven cancers affecting women, including #LGSOC, gynecological cancers and more.

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

Today @US_FDA granted Orphan Drug Designation to avutometinib alone or in combination with defactinib for #lowgradeserous #ovariancancer, reinforcing our commitment to deliver new treatment options for the more than 6,000 US women affected by #LGSOC. bit.ly/434g1dj

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

This year at #AACR24 we will be sharing 5 preclinical data presentations, including for the first time with our partner GenFleet Therapeutics, anti-tumor efficacy data from GFH374/VS-7375, a KRAS G12D (ON/OFF) inhibitor. #RASmutations Learn more: bit.ly/48GnIrt

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

2/3 of American women feel they have no control over their ovarian health. This is shocking – women point to the need for more patient education when it comes to their #lowgradeserous #ovariancancer or #LGSOC. To learn more visit: bit.ly/3Uuw6a2

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

We are committed to supporting research offering breakthrough cancer therapy to patients so that no one, including those with rare diseases like #lowgradeserous #ovariancancer #LGSOC, runs out of treatment options. #DiseaseDay #RareDiseases

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

The #LGSOCPatientImpactSurvey w/ @HarrisPoll reveals U.S. women aren’t prioritizing their ovarian health & awareness about ovarian cancer, including rare form #LGSOC. Find survey results & info on treating & managing this disease bit.ly/3Uuw6a2

VerastemOncolog Profile Picture

Verastem Oncology @VerastemOncolog

2 months ago

Our groundbreaking survey of patients with #LGSOC reveals that <1 in 5 U.S. women feel knowledgeable about ovarian cancer. Let’s Talk About LGSOC offers a place for patients, like Ellie, and caregivers to learn more about this rare cancer. Learn more: bit.ly/3Uuw6a2

Trends for United States

#GoAvsGo
8.687 posts
#bucciovertimechallenge
5.697 posts
Miles Wood
2.573 posts
#ThunderUp
4.708 posts
Rangers
47,1 B posts
Shai
26,2 B posts
Igor
21,2 B posts
Canes
18,6 B posts
#PumpRules
19,3 B posts
Trocheck
8.766 posts
Chet
13,5 B posts
Jalen Williams
3.446 posts
Trouba
6.339 posts
Aaron Wiggins
3.185 posts
Gafford
5.161 posts
Tony Brothers
1.258 posts
Drea Kelly
1.305 posts
Double OT
3.848 posts
Lu Dort
2.601 posts
Hintz

You might like

Precision science. Pioneering medicine. Patient driven.
LexPharma
@LexPharma
452 Followers
FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer.
FDA Oncology
@FDAOncology
38K Followers
The most flexible US mobile provider. No bulk buying and no contract. Phone plans from $5 to $25 with great features available.
tellomobile
@tellomobile
6K Followers
The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=51.1
The Lancet Oncology
@TheLancetOncol
58K Followers
Trusted knowledge base of practical information and resources focused on hematology and critical care medicine.
Hematology Advisor
@HematologyAdv
2K Followers
Enanta is a biotechnology company dedicated to creating small molecule drugs for virology and immunology indications. Twitter guidelines: https://t.co/8XhH4BLvxe
Enanta Pharmaceutical..
@EnantaPharma
543 Followers
Professor, Dept of Leukemia, MD Anderson Cancer Center | Director, CAR-T Leukemia Program | #CLL #ALL #TcellRx | via @aiims_newdelhi | Tweets: my own opinions
Nitin Jain
@NitinJainMD
8K Followers
MiNK is a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf, $INKT cell therapies to treat cancer and other immune-mediated diseases
MiNK Therapeutics
@MiNK_iNKT
647 Followers
Since 1948, the Jimmy Fund has supported the fight against cancer in children and adults at Boston's @DanaFarber Cancer Institute. | https://t.co/Dcr4R0DRtn
The Jimmy Fund
@TheJimmyFund
47K Followers
Developing life enhancing treatments for chronic respiratory diseases
Verona Pharma
@VeronaPharma
635 Followers
Clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.
Gossamer Bio
@GossamerBio
549 Followers
Oncology news and insights from leading researchers and cancer centers.
Targeted Oncology
@TargetedOnc
20K Followers
Official Twitter for US Oncology business of EMD Serono a business of Merck KGaA Darmstadt, Germany. Intended for U.S. audience CG: ➡️https://t.co/DN8q8OvEDb
EMD Serono Oncology U..
@EMDOncologyUS
529 Followers
Stoke Therapeutics is addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines.
Stoke Therapeutics
@StokeTx
1K Followers
An online platform where doctors, scientists, patients & families share treatment info, experiences & learn of new #PancreaticCancer research💜#PancChat #PancSM
Let's Win Pancreatic ..
@letswinpc
8K Followers